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Introduction {#sec005}
============

Administrative healthcare databases collect a great amount of demographic data, drug prescriptions, diagnostic and therapeutic procedures. The information contained in these databases are not collected with a research purpose and, to be used for this scope, they should be previously validated.

Peptic ulcer is a common disease with a worldwide prevalence of 5--10% and an incidence of 0.1--0.3% per year \[[@pone.0235714.ref001]\]. The most frequent complications of peptic ulcer disease are perforation and bleeding. A systematic review reported an annual incidence of hemorrhage in the general population ranging from 0.02 to 0.06%, and an annual incidence of perforation ranging from 0.004 to 0.014% \[[@pone.0235714.ref002]\]. Traditionally risk factors for peptic ulcer disease involve a hypersecretory acid environment, dietary factors, and stress, while detection of Helicobacter pylori infection, frequent use of nonsteroidal anti-inflammatory drugs (NSAIDs), alcohol consumption, and smoking abuse have modified the etiology of this disease.

The frequent use of NSAIDs and anticoagulant drugs for the treatment of cardiovascular and cerebrovascular diseases represents the main cause of gastrointestinal bleeding. The present study is part of two other validation studies of cardiovascular \[[@pone.0235714.ref003]\] and cerebrovascular diseases \[[@pone.0235714.ref004]\].

The objective of this study was to assess the accuracy of the ICD-9 codes in identifying patients with peptic ulcer and gastrointestinal hemorrhage in the administrative database of the Regional Health Authority of Umbria.

Materials and methods {#sec006}
=====================

Setting and data source {#sec007}
-----------------------

### Administrative database {#sec008}

The index test considered in the present study was the hospital discharge abstract database of the Umbria Region (Italy). This database collects data on all hospital admissions of all 890,000 residents, and contains information on personal demographics, admitting and discharge date, vital status, ICD-9 codes of primary and secondary diagnoses, diagnostic tests, medications, and surgical procedures. Each resident has a unique personal identifier within the database that allows a record linkage with other databases, such as the drug prescription database.

### Source population {#sec009}

We considered all the residents in the Umbria Region \> 18 years discharged from seven hospitals (Perugia, Terni, Foligno, Città di Castello, Orvieto, Gubbio-Gualdo Tadino, Spoleto) between 2012 and 2014 with a diagnosis of peptic ulcer or gastrointestinal hemorrhage. We excluded residents hospitalised outside the regional territory of Umbria.

### Case selection and sampling method {#sec010}

The methodology of this study for case selection and sampling method is based on that described on our research protocol for cardiovascular and cerebrovascular diseases \[[@pone.0235714.ref005]\]. Through a simple randomization method using SAS 9.4 we selected from the administrative database of Umbria four cohorts of "cases", that is incident patients with a diagnosis of peptic ulcer and gastrointestinal hemorrhage between 2012 and 2014 having in the discharge abstract the ICD-9 codes located in primary position of gastric ulcer (ICD-9 code 531), duodenal ulcer (code 532), gastrojejunal ulcer (codes 534), gastrointestinal hemorrhage (codes 578). The ICD-9 code 533 "Peptic ulcer, site unspecified" was initially considered for validation, but we found only five cases with this diagnosis in primary position and we decided to exclude it from the final analysis. From our cohorts we excluded patients discharged with the same diagnosis from 2007 to 2011.

From original cohorts we extracted a random sample of 130 cases for the codes 531, 532, and 578, while for the code 534 we considered all the patients discharged. In addition, we selected a cohort of "non-cases", i.e. patients who had been discharged in the same period in a gastroenterology ward with a diagnosis other than peptic ulcer or gastrointestinal hemorrhage, from which we extracted a random sample of 80 patients. This sample of non-cases was used as control group for each of the four diseases.

Chart abstraction and case ascertainment {#sec011}
----------------------------------------

We retrieved the following data from the medical charts of cases and non-cases: clinical chart number, date of birth, gender, dates of hospital admission and discharge, hospital discharge procedure, primary and secondary diagnoses, medical history, any diagnostic procedure and treatment that contributed to the diagnosis of the disease.

Clinical charts were reviewed by physicians previously trained in data extraction. We performed a pilot phase in which the reviewers independently examined 25 clinical charts, with a level of agreement very high (k\> 0.88). To achieve a higher level of agreement the working group discussed about the cases of disagreement that were solved by the judgement of a third reviewer (GA). Data extraction was performed using predetermined data extraction sheets.

Validation criteria {#sec012}
-------------------

To validate the ICD-9 codes for peptic ulcer we considered endoscopy, radiology, and surgery, while to validate gastrointestinal hemorrhage we considered the occurrence of hematemesis, melena, and rectal bleeding.

Statistical analysis {#sec013}
--------------------

We calculated a sample of 125 cases and 80 non-cases in order to obtain an expected positive predictive value (PPV) of 73% (estimated median from available published studies \[[@pone.0235714.ref006]--[@pone.0235714.ref011]\]) and a negative predictive value (NPV) of 90% (our assumption in absence of published evidence) with a maximum width of the 95% CI of 16% according to exact calculation \[[@pone.0235714.ref012]\].

For each ICD-9 code, we calculated sensitivity, specificity, PPV and NPV, along with their corresponding 95% CI.

Reporting {#sec014}
---------

Quality of reporting was guaranteed following the Standards for Reporting Diagnostic Accuracy (STARD) criteria \[[@pone.0235714.ref013]\] ([S1 Table](#pone.0235714.s001){ref-type="supplementary-material"}).

Ethics statement {#sec015}
----------------

Ethics approval has been obtained from the Regional Ethics Committee of Umbria (CEAS), registry No 2695/15 of 16/12/2015.

Results {#sec016}
=======

A random sample of 130 medical charts for each cohort of cases, and 80 medical charts from the cohort of non-cases was selected. The total number of clinical charts reviewed for cases was 445: 128 each for gastric (ICD-9 code 531) and duodenal ulcer (ICD-9 code 532), 62 for gastrojejunal ulcer (ICD-9 code 534), and 127 for gastrointestinal hemorrhage (ICD-9 code 578). For gastrojejunal ulcer, we considered all the available hospital admissions in the period 2012--2014. In the meanwhile, we selected 80 clinical charts for non-cases. For each ICD-9 code, characteristics of the patients are described in Tables [1](#pone.0235714.t001){ref-type="table"}--[4](#pone.0235714.t004){ref-type="table"}.

10.1371/journal.pone.0235714.t001

###### Characteristics of patients with gastric ulcer.

![](pone.0235714.t001){#pone.0235714.t001g}

  ------------------------------------------------------------------------------------- ------------
  **Gastric ulcer**                                                                     
  **Incident cases** (N medical charts reviewed)                                        128
  **ICD-9 code, N (%)**                                                                 
  531 Gastric ulcer                                                                     128 (100%)
  531.0 Acute with hemorrhage                                                           78 (61%)
  531.1 Acute with perforation                                                          15 (12%)
  531.2 Acute with hemorrhage and perforation                                           2 (2%)
  531.3 Acute without mention of hemorrhage or perforation                              21 (16%)
  531.4 Chronic or unspecified with hemorrhage                                          4 (3%)
  531.5 Chronic or unspecified with perforation                                         \-
  531.6 Chronic or unspecified with hemorrhage and perforation                          \-
  531.7 Chronic without mention of hemorrhage or perforation                            2 (2%)
  531.9 Unspecified as acute or chronic, without mention of hemorrhage or perforation   6 (5%)
  **Sex, N (%)**                                                                        
  Male                                                                                  77 (60%)
  Female                                                                                51 (40%)
  **Age, N (%)**                                                                        
  *\< 60*                                                                               25 (20%)
  *60--79*                                                                              55 (43%)
  *≥ 80*                                                                                48 (38%)
  **Instrumental examinations, N (%)**                                                  
  Gastroscopy                                                                           117 (91%)
  Abdominal ultrasound                                                                  43 (34%)
  Abdominal CT                                                                          14 (11%)
  Abdominal x-ray                                                                       10 (8%)
  **Histological documentation, N (%)**                                                 
  Biopsy from gastroscopy                                                               55 (43%)
  Biopsy from surgery                                                                   9 (7%)
  **Surgical procedures, N (%)**                                                        
  Gastrectomy                                                                           6 (5%)
  Other surgical procedures                                                             7 (5%)
  **Laboratory analyses, N (%)**                                                        
  Haemoglobin levels                                                                    122 (95%)
  ------------------------------------------------------------------------------------- ------------

10.1371/journal.pone.0235714.t002

###### Characteristics of patients with duodenal ulcer.

![](pone.0235714.t002){#pone.0235714.t002g}

  ------------------------------------------------------------------------------------- ------------
  **Duodenal ulcer**                                                                    
  **Incident cases** (N medical charts reviewed)                                        128
  **ICD-9 code, N (%)**                                                                 
  532 Duodenal ulcer                                                                    128 (100%)
  532.0 Acute with hemorrhage                                                           70 (55%)
  532.1 Acute with perforation                                                          6 (5%)
  532.2 Acute with hemorrhage and perforation                                           4 (3%)
  532.3 Acute without mention of hemorrhage or perforation                              20 (16%)
  532.4 Chronic or unspecified with hemorrhage                                          11 (9%)
  532.5 Chronic or unspecified with perforation                                         6 (5%)
  532.6 Chronic or unspecified with hemorrhage and perforation                          1 (1%)
  532.7 Chronic without mention of hemorrhage or perforation                            1 (1%)
  532.9 Unspecified as acute or chronic, without mention of hemorrhage or perforation   9 (7%)
  **Sex**                                                                               
  Male                                                                                  80 (63%)
  Female                                                                                48 (38%)
  **Age, N (%)**                                                                        
  \< 60                                                                                 42 (33%)
  60--79                                                                                43 (34%)
  ≥ 80                                                                                  43 (34%)
  **Instrumental examinations, N (%)**                                                  
  Gastroscopy                                                                           115 (90%)
  Abdominal ultrasound                                                                  41 (32%)
  Abdominal CT                                                                          13 (10%)
  Abdominal x-ray                                                                       14 (11%)
  **Histological documentation, N (%)**                                                 
  Biopsy from gastroscopy                                                               37 (29%)
  Biopsy from surgery                                                                   7 (5%)
  **Surgical procedures, N (%)**                                                        
  Gastrectomy                                                                           5 (4%)
  Other surgical procedures                                                             13 (10%)
  **Laboratory analyses, N (%)**                                                        
  Haemoglobin levels                                                                    122 (95%)
  ------------------------------------------------------------------------------------- ------------

10.1371/journal.pone.0235714.t003

###### Characteristics of patients with gastrojejunal ulcer.

![](pone.0235714.t003){#pone.0235714.t003g}

  ------------------------------------------------------------------------------------- -----------
  **Gastrojejunal ulcer**                                                               
  **Incident cases** (N medical charts reviewed)                                        62
  **ICD-9 code, N (%)**                                                                 
  534 Gastrojejunal ulcer                                                               62 (100%)
  534.0 Acute with hemorrhage                                                           47 (76%)
  534.1 Acute with perforation                                                          4 (6%)
  534.2 Acute with hemorrhage and perforation                                           \-
  534.3 Acute without mention of hemorrhage or perforation                              3 (5%)
  534.4 Chronic or unspecified with hemorrhage                                          3 (5%)
  534.5 Chronic or unspecified with perforation                                         \-
  534.6 Chronic or unspecified with hemorrhage and perforation                          2 (3%)
  534.7 Chronic without mention of hemorrhage or perforation                            1 (2%)
  534.9 Unspecified as acute or chronic, without mention of hemorrhage or perforation   2 (3%)
  **Sex**                                                                               
  Male                                                                                  34 (55%)
  Female                                                                                28 (45%)
  **Age, N (%)**                                                                        
  \< 60                                                                                 8 (13%)
  60--79                                                                                26 (42%)
  ≥ 80                                                                                  28 (45%)
  **Instrumental examinations, N (%)**                                                  
  Gastroscopy                                                                           56 (90%)
  Abdominal ultrasound                                                                  14 (23%)
  Abdominal CT                                                                          8 (13%)
  Abdominal x-ray                                                                       4 (6%)
  **Histological documentation, N (%)**                                                 
  Biopsy from gastroscopy                                                               21 (34%)
  Biopsy from surgery                                                                   2 (3%)
  **Surgical procedures, N (%)**                                                        
  Gastrectomy                                                                           2 (3%)
  Other surgical procedures                                                             3 (5%)
  **Laboratory analyses, N (%)**                                                        
  Haemoglobin levels                                                                    61 (98%)
  ------------------------------------------------------------------------------------- -----------

10.1371/journal.pone.0235714.t004

###### Characteristics of patients with gastrointestinal hemorrhage.

![](pone.0235714.t004){#pone.0235714.t004g}

  --------------------------------------------------------- ------------
  **Gastrointestinal hemorrhage**                           
  **Incident cases** (N medical charts reviewed)            127
  **ICD-9 code, N (%)**                                     
  578 Gastrointestinal hemorrhage                           127 (100%)
  578.0 Hematemesis                                         13 (10%)
  578.1 Blood in stool                                      70 (55%)
  578.9 Hemorrhage of gastrointestinal tract, unspecified   44 (35%)
  **Sex**                                                   
  Male                                                      66 (52%)
  Female                                                    61 (48%)
  **Age, N (%)**                                            
  \< 60                                                     15 (12%)
  60--79                                                    57 (45%)
  ≥ 80                                                      55 (43%)
  **Instrumental examinations, N (%)**                      
  Gastroscopy                                               58 (46%)
  Colonoscopy                                               62 (49%)
  Abdominal ultrasound                                      29 (23%)
  Abdominal CT                                              14 (11%)
  Abdominal x-ray                                           4 (3%)
  **Histological documentation, N (%)**                     
  Biopsy from gastroscopy                                   10 (8%)
  Biopsy from colonscopy                                    15 (12%)
  **Laboratory analyses, N (%)**                            
  Haemoglobin levels                                        124 (98%)
  **Deaths, N (%)**                                         
  Patients deceased during hospital admission               11 (9%)
  --------------------------------------------------------- ------------

A minimal anonymized dataset is provided as an additional support information file ([S1 Dataset](#pone.0235714.s002){ref-type="supplementary-material"}).

The cross tabulation reporting the index test and reference standard results is reported in [Table 5](#pone.0235714.t005){ref-type="table"}.

10.1371/journal.pone.0235714.t005

###### Cross tabulation of the index test (ICD-9-CM code) for the results of the reference standard (medical chart).

![](pone.0235714.t005){#pone.0235714.t005g}

                                    True Positive   False Positive   True Negative   False Negative
  --------------------------------- --------------- ---------------- --------------- ----------------
  531 Gastric ulcer                 117             11               78              2
  532 Duodenal ulcer                126             2                80              0
  534 Gastrojejunal ulcer           28              34               80              0
  578 Gastrointestinal hemorrhage   119             8                75              5

Gastric ulcer {#sec017}
-------------

We identified 358 patients having the ICD-9 code 531 in primary position between 2012 and 2014. From this cohort, we extracted a sample of 130 cases, of these 128 were analysed (two clinical charts were not available).

The general characteristics of the patients with gastric ulcer are described in [Table 1](#pone.0235714.t001){ref-type="table"}. Most of patients were males (60%) and \> 60 years (80%).

Gastroscopy was the diagnostic test mostly performed (91%), followed by abdominal ultrasound (34%). We found histological documentation from biopsy in 43% of clinical charts, while the surgical procedures occurred in 10% of patients.

The diagnostic accuracy measures derived from the cross tabulation ([Table 5](#pone.0235714.t005){ref-type="table"}) are: sensitivity 98% (95% CI: 94%--100%), specificity 88% (95% CI: 79%--94%), PPV 91% (95% CI: 85%--96%), and NPV 98% (95% CI: 91%--100%). Misclassification of cases and non-cases is described in [Table 6](#pone.0235714.t006){ref-type="table"}.

10.1371/journal.pone.0235714.t006

###### Reasons for incorrect identification of cases and controls.

![](pone.0235714.t006){#pone.0235714.t006g}

                                                                                                                      531 Gastric ulcer                                                                              532 Duodenal ulcer                                  534 Gastrojejunal ulcer                                                                                  578 Gastrointestinal hemorrhage
  ------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- --------------------------------------------------- -------------------------------------------------------------------------------------------------------- ----------------------------------------
  **FALSE POSITIVES**                                                                                                 \- Misclassifications (3 gastrojejunal ulcers and 1 duodenal ulcer): n.4;                      \- Duodenal ulcer not found by gastroscopy: n. 2.   \- Misclassifications (19 gastric ulcers, 6 duodenal ulcers, 1 occlusion of cerebral arteries): n. 26;   \- Blood in stool not found: n. 2;
  \- Misclassifications (2 gastric ulcers, 1 duodenal ulcer, 2 gastrojejunal ulcers): n. 5;                                                                                                                                                                                                                                                                                       
  \- Gastric ulcer not found by gastroscopy: n. 6;                                                                                                                                                                                                                                                                                                                                
  \- Gastrojejunal ulcer not found by gastroscopy: n. 7;                                                                                                                                                                                                                                                                                                                          
  \- Hemorrhage of gastrointestinal tract not found: n. 1.                                                                                                                                                                                                                                                                                                                        
  \- Gastroscopy report not found in the clinical chart: n. 1.                                                                                                                                                                                                                                                                                                                    
  \- Gastroscopy report not found in the clinical chart and histology from biopsy negative for gastric ulcer: n. 1.                                                                                                                                                                                                                                                               
  **FALSE NEGATIVES**                                                                                                 Patients with gastric ulcer diagnosed by gastroscopy (code 531 in secondary position): n. 2.   None                                                None                                                                                                     \- Patients with blood in stool: n. 4;
  \- Patient with hematemesis: n. 1.                                                                                                                                                                                                                                                                                                                                              

The false positives (n. 11) were due to coding errors, and gastroscopy or histology by biopsy negative for gastric ulcer, while the false negatives (n.2) were patients with gastric ulcer diagnosed by gastroscopy (code 531 in secondary position).

Duodenal ulcer {#sec018}
--------------

We identified 351 cases having the ICD-9 code 532 in primary position between 2012 and 2014. From this cohort, we extracted a sample of 130 cases, of these 128 were analysed (two clinical charts were not available).

The general characteristics of the patients with duodenal ulcer are described in [Table 2](#pone.0235714.t002){ref-type="table"}. Most of patients were males (63%), while patients were equally distributed between the three age classes considered.

Gastroscopy was the diagnostic test mostly performed (90%), followed by abdominal ultrasound (32%). We found histological documentation from biopsy in 29% of clinical charts, while the surgical procedures occurred in 14% of patients.

The diagnostic accuracy measures derived from the cross tabulation ([Table 5](#pone.0235714.t005){ref-type="table"}) are: sensitivity 100% (95% CI: 97%--100%), specificity 98% (95% CI: 92%--100%), PPV 98% (95% CI: 95%--100%), and NPV 100% (95% CI: 96%--100%). Misclassification of cases and non-cases is described in [Table 6](#pone.0235714.t006){ref-type="table"}.

The false positives (n. 2) were due to duodenal ulcer not found by gastroscopy.

Gastrojejunal ulcer {#sec019}
-------------------

We identified 63 overall cases having the ICD-9 code 534 in primary position between 2012 and 2014, and of these 62 were analysed (one clinical chart was not available).

The general characteristics of the patients with gastrojejunal ulcer are described in [Table 3](#pone.0235714.t003){ref-type="table"}. Most of patients were males (55%) and \> 60 years (87%).

Gastroscopy was the diagnostic test mostly performed (90%), followed by abdominal ultrasound (23%). We found histological documentation from biopsy in 34% of clinical charts, while the surgical procedures occurred in 8% of patients.

The diagnostic accuracy measures derived from the cross tabulation ([Table 5](#pone.0235714.t005){ref-type="table"}) are: sensitivity 100% (95% CI: 88%--100%), specificity 70% (95% CI: 61%--78%), PPV 45% (95% CI: 33%--58%), and NPV 100% (95% CI: 96%--100%). Misclassification of cases and non-cases is described in [Table 6](#pone.0235714.t006){ref-type="table"}.

The false positives (n. 34) were mostly due to coding errors (n. 26), and to gastroscopy negative for gastrojejunal ulcer or not reported (n. 8).

Gastrointestinal hemorrhage {#sec020}
---------------------------

We identified 947 patients having the ICD-9 code 578 in primary position between 2012 and 2014. From this cohort, we extracted a sample of 130 cases, of these 127 were analysed (three clinical charts were not available).

The general characteristics of the patients with gastrointestinal hemorrhage are described in [Table 4](#pone.0235714.t004){ref-type="table"}. Patients were equally distributed between sex, while most of patients were \> 60 years (88%).

Gastroscopy and coloscopy were the diagnostic tests mostly performed (46% and 49% respectively), followed by abdominal ultrasound (23%). We found that almost all patients (98%) had haemoglobin levels from laboratory analysis. Nine percent of patients died during hospital stay.

The diagnostic accuracy measures derived from the cross tabulation ([Table 5](#pone.0235714.t005){ref-type="table"}) are: sensitivity 96% (95% CI: 91%--99%), specificity 90% (95% CI: 82%--96%), PPV 94% (95% CI: 88%--97%), and NPV 94% (95% CI: 86%--98%). Misclassification of cases and non-cases is described in [Table 6](#pone.0235714.t006){ref-type="table"}.

The false positives (n. 8) were due to coding errors (n. 5), and blood in stool or hemorrhage of gastrointestinal tract not found (n. 3), while the false negatives (n. 5) were patients having blood in stool or hematemesis.

Discussion {#sec021}
==========

The present study is one of the few in Italy and the first in Umbria Region validating the ICD-9 codes related to peptic ulcer and gastrointestinal hemorrhage using clinical charts as a reference standard. We performed a literature search to find studies validating the same diseases in Italy or worldwide. We did not find any systematic review on this topic, but only primary diagnostic accuracy studies validating the same ICD-9 codes of our study, with some differences on study design and ICD-9 sub-codes considered.

The results of our study in terms of PPV are in line with those found in other validation studies considering clinical charts as the reference standard.

Cattaruzzi et al. \[[@pone.0235714.ref007]\] performed a validation study in the Italian region of Friuli--Venezia Giulia, identifying patients with upper gastrointestinal bleeding (UGIB) and perforation to estimate the risk of hospitalization associated with intake of nonsteroidal antiinflammatory drugs (NSAIDs) and other drugs. They considered the same ICD-9 codes of our study (peptic ulcer and gastrointestinal bleeding), limited to the sub-codes of hemorrhage or perforation. The overall PPV for the code 531 for a confirmed site of UGIB was 89%, 532 code 83%, 534 code 46%, and 578 code ranging from 59% to 70%.

Another more recent Italian validation study having the same objectives of the previous study \[[@pone.0235714.ref007]\] was carried out by Pisa et al. \[[@pone.0235714.ref009]\]. The PPV results were: 531 code 66%, 532 code 92%, 534 code 33%, and 578 code 33--51%. Compared to Pisa \[[@pone.0235714.ref009]\] results, our study found a higher PPV value for the codes 531 and 578.

In addition, we retrieved other three international studies on this topic \[[@pone.0235714.ref006], [@pone.0235714.ref010], [@pone.0235714.ref011]\]. Raiford and colleagues \[[@pone.0235714.ref010]\] calculated the PPV of ICD-9 codes used to identify cases of complicated peptic ulcer disease from the Saskatchewan Hospital automated database. The overall PPV for the code 531 for a confirmed site of UGIB was 83%, 532 code 81%, and 578 code 84--88%; no case was detected for 534 code.

Another study conducted in USA \[[@pone.0235714.ref006]\] evaluated the PPV of ICD-9 codes for cases of peptic ulcers and upper gastrointestinal bleeding documented in eight large health maintenance organizations (HMOs) databases. The authors evaluated the codes 531 and 534 together. The PPVs were 77% for the code 532 of duodenal ulcer, 76% for gastric/gastrojejunal ulcer (codes 531+534), and 7% for gastrointestinal hemorrhage. The PPV for the code 578 was very lower compared to other studies \[[@pone.0235714.ref007], [@pone.0235714.ref010]\], probably due to more stringent criteria for case definition of upper gastrointestinal hemorrhage (from gastric or duodenal ulcer, hemorrhagic gastritis, or duodenitis) confirmed by surgery, endoscopy, X-ray, or autopsy.

The last study found was that of Viborg et al. \[[@pone.0235714.ref011]\] developed in Denmark. This study was aimed to validate the ICD-10 codes of peptic ulcer in the Danish National Patient Registry (DNPR) by estimating PPVs only for gastric and duodenal ulcer diagnoses. The PPV of gastric ulcer diagnosis (ICD-10 code K25) in DNPR was 90%, and for duodenal ulcer (ICD-10 code K26) was 94%.

All the studies found assessed only the PPV, not considering a control group of patients without a diagnosis of peptic ulcer or gastrointestinal hemorrhage. Instead, in order to estimate sensitivity and specificity, in absence of a disease registry for peptic ulcers and gastrointestinal hemorrhage that constitutes the real prevalence of the diseases, we chose to consider a sample of "non-cases", i.e. patients who had been discharged in the same period in a gastroenterology ward with a diagnosis other than peptic ulcer or gastrointestinal hemorrhage, to individuate possible false negatives.

Another consideration is about the lower value of PPV found in our study for the code 534 compared to the other codes, mostly due to several coding errors. However, this low PPV is comparable with those reported in other above-mentioned studies \[[@pone.0235714.ref007], [@pone.0235714.ref009]\].

Regarding the generalizability of our study, we want to highlight that, in general, validation studies of administrative databases are context-specific due to differences that may exist in demographics, disease prevalence, and standards of care among different contexts, and thus our results can confidently be applied only to the regional setting of Umbria. However, our methodology could be replicated in other regional or national settings in order to identify possible differences in diagnostic accuracy measures results.

Strengths and limitations {#sec022}
-------------------------

A strength of our study is that we used medical charts as the reference standard for case ascertainment of peptic ulcer and gastrointestinal hemorrhage.

Our methodology derives from a published protocol on cardiovascular and cerebrovascular diseases. Quality of reporting was ensured following the STARD 2015 criteria \[[@pone.0235714.ref013]\] for diagnostic accuracy studies. Finally, we considered detailed and explicit criteria for case ascertainment, and the data extraction from clinical charts was performed in duplicate and independent way.

We acknowledge that a potential limitation of our study is that we evaluated the accuracy of ICD-9 codes located only in primary position. We chose to limit our analysis only to the codes in primary position because, according to the Italian legislation, the primary diagnosis constitutes the main cause of the need for treatment and/or diagnostic tests, and is mainly responsible for the use of resources.

Another possible limitation of the present study concerns the generalizability of our results in other geographical settings with different demographic characteristics and disease prevalence.

Conclusion {#sec023}
==========

In this study, we validated the ICD-9 diagnostic codes for peptic ulcer and gastrointestinal hemorrhage using the Regional Healthcare administrative database of Umbria. Most of the ICD-9 codes considered (531, 532, and 578) showed a high level for all the diagnostic accuracy measures. The ICD-9 code 534 had a very high level of sensitivity and NPV, but lower levels of specificity and PPV due to false positives, mainly for coding errors.

According to our results, the validated codes for peptic ulcer and gastrointestinal hemorrhage could be used in future studies evaluating epidemiological and clinical research on health services.

Supporting information {#sec024}
======================

###### STARD-2015-checklist.

(DOCX)

###### 

Click here for additional data file.

###### Minimal anonymized dataset.

(PDF)

###### 

Click here for additional data file.
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PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: In this study authors carried out a validation study by using the Regional Healthcare administrative database of Umbria. As mentioned in the manuscript authors have published other article aimed to validate cardiovascular and cerebrovascular diseases. The article is well written, understandable and well structured. However, I have some comments that authors should take into account:

1\) In the method section, the authors declare that they used ICD9 included in the primary position of the hospital discharge database. I am aware that sometime in second position can be included only a few information, but I was wondering why authors did not include also this codes in the validation (i.e., at least for most important event such as gastric haemorrhage).

2\) In the discussion authors declare that other studies have been performed in Italy with the same purpose. Can authors better specify the difference among the other two studies and their one? In addition, can authors specify what their paper adds to the Italian literature on this topic?

3\) I partly agree with authors's sentence "....validation studies of administrative database are context-specific, and thus our results can be applied only to the regional setting of Umbria". What about the use/adaptation of the same codes in other Italian region? Do authors suppose a different diagnosis procedures/codes used in other Italian regions? If yes, why?

Reviewer \#2: Dear authors,

Your manuscript gives interesting informations on the accuracy of ICD-9 codes in identifying patients with peptic ulcer and gastrointestinal haemorrhage in the regional healthcare administrative database of Umbria and the validated codes will be useful for future epidemiological studies on health services.

However, there are certain points that need to be clarified or better discussed:

1\) In the \"setting and datasource paragraph\", no information on medical charts were presented. Please explain the origin of these medical charts. From which hospital did you retrive these data? Is there a data warehouse collecting these informations?

2\) Despite the great effort in analysing sensitivity and specificity of ICD-9codes, the authors measure those values only on the percentage of 80 "non cases". Do you know the "real prevalence" of patients with these diseases in the Umbria region between 2012 and 2014? Is there a pathology registry in Umbria to compare the  prevalence of diseases found using administrative data with the "real prevalence" of these diseases in an already validated registry? If these data cannot be recovered (or are inexistent) please discuss in the discussion section.

3\) Have you performed any sensitivity analyses considering not only ICD-9 CM codes in the primary position but also using the secondary positions? If not, please  discuss further the motivations in using only primary position codes in the limitations of the study.

4\) Please define abbreviations upon first appearance in the text. PPV and NPV abbreviation was firstly used in the \"statistical analysis" section but the explanation is reported more than once in the "results" section.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: Yes: Andrea Spini

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Reviewer \#1: In this study authors carried out a validation study by using the Regional Healthcare administrative database of Umbria. As mentioned in the manuscript authors have published other article aimed to validate cardiovascular and cerebrovascular diseases. The article is well written, understandable and well structured.

Thank you for your positive comment.

However, I have some comments that authors should take into account:

1\) In the method section, the authors declare that they used ICD9 included in the primary position of the hospital discharge database. I am aware that sometime in second position can be included only a few information, but I was wondering why authors did not include also this codes in the validation (i.e., at least for most important event such as gastric haemorrhage).

Authors response: We decided to limit our validation study to only consider the codes in primary position because, according to the Italian legislation, the primary diagnosis constitutes the main cause of the need for treatment and/or diagnostic tests, and is mainly responsible for the use of resources.

We added this sentence to the study limitations: "We acknowledge that a potential limitation of our study is that we evaluated the accuracy of ICD-9 codes located only in primary position. We chose to limit our analysis only to the codes in primary position because, according to the Italian legislation, the primary diagnosis constitutes the main cause of the need for treatment and/or diagnostic tests, and is mainly responsible for the use of resources".

2\) In the discussion authors declare that other studies have been performed in Italy with the same purpose. Can authors better specify the difference among the other two studies and their one? In addition, can authors specify what their paper adds to the Italian literature on this topic?

Authors response: The main difference between our study and the other two Italian studies on this topic is that we were interested in validating the complete ICD-9 codes 531, 532, 534, and 578, while Cattaruzzi et al. and Pisa et al. considered the same ICD-9 codes of our study (peptic ulcer and gastrointestinal hemorrhage), but limited to the sub-codes of hemorrhage or perforation, with the aim to identify patients with upper gastrointestinal bleeding (UGIB) associated with intake of nonsteroidal antiinflammatory drugs (NSAIDs) and other drugs.

We decided to perform our study in order to validate for the first time the Regional administrative database of Umbria for these specific codes, that could be used in future to perform other epidemiological studies and health services research.

We added this in the discussion section: "The present study is one of the few in Italy and the first in Umbria Region validating the ICD-9 codes related to peptic ulcer and gastrointestinal hemorrhage using clinical charts as a reference standard".

3\) I partly agree with authors's sentence "....validation studies of administrative database are context-specific, and thus our results can be applied only to the regional setting of Umbria". What about the use/adaptation of the same codes in other Italian region? Do authors suppose a different diagnosis procedures/codes used in other Italian regions? If yes, why?

Authors response: In general, results that originate from a healthcare database are immediately applicable only to the setting in which such database has been validated, due to differences that may exist with respect to demographics, disease prevalence, and standards of care, among different regions.

However, we think that our methodology could be replicated in other settings in order to identify possible differences in diagnostic accuracy results.

We amended the text as follows: "Regarding the generalizability of our study, we want to highlight that, in general, validation studies of administrative databases are context-specific due to differences that may exist in demographics, disease prevalence, and standards of care among different contexts, and thus our results can confidently be applied only to the regional setting of Umbria".

Reviewer \#2: Dear authors,

Your manuscript gives interesting informations on the accuracy of ICD-9 codes in identifying patients with peptic ulcer and gastrointestinal haemorrhage in the regional healthcare administrative database of Umbria and the validated codes will be useful for future epidemiological studies on health services.

Thank you for your positive comment.

However, there are certain points that need to be clarified or better discussed:

1\) In the \"setting and datasource paragraph\", no information on medical charts were presented. Please explain the origin of these medical charts. From which hospital did you retrive these data? Is there a data warehouse collecting these informations?

Authors response: We added in the text the description of the hospitals where the clinical charts came from: "We considered all the residents in the Umbria Region \> 18 years discharged from seven hospitals (Perugia, Terni, Foligno, Città di Castello, Orvieto, Gubbio-Gualdo Tadino, Spoleto) between 2012 and 2014 with a diagnosis of peptic ulcer or gastrointestinal haemorrhage".

We presented a minimal anonymized dataset containing the main characteristics of the study sample (see Supplementary material).

2\) Despite the great effort in analysing sensitivity and specificity of ICD-9codes, the authors measure those values only on the percentage of 80 "non cases". Do you know the "real prevalence" of patients with these diseases in the Umbria region between 2012 and 2014? Is there a pathology registry in Umbria to compare the prevalence of diseases found using administrative data with the "real prevalence" of these diseases in an already validated registry? If these data cannot be recovered (or are inexistent) please discuss in the discussion section.

Authors response: Unfortunately, in Umbria there is not a pathology registry for ulcers or gastrointestinal hemorrhage, and therefore we do not know the real prevalence of the diseases. We based our estimation of sensitivity and specificity using a sample of "non-cases", i.e. patients who had been discharged in the same period in a gastroenterology ward with a diagnosis other than peptic ulcer or gastrointestinal hemorrhage, from which we extracted a random sample of 80 patients.

We added in the discussion section the following sentence: "Instead, in order to estimate sensitivity and specificity, in absence of a disease registry for peptic ulcers and gastrointestinal hemorrhage that constitutes the real prevalence of the diseases, we chose to consider a sample of "non-cases", i.e. patients who had been discharged in the same period in a gastroenterology ward with a diagnosis other than peptic ulcer or gastrointestinal hemorrhage, to individuate possible false negatives".

3\) Have you performed any sensitivity analyses considering not only ICD-9 CM codes in the primary position but also using the secondary positions? If not, please discuss further the motivations in using only primary position codes in the limitations of the study.

Authors response: We did not perform a sensitivity analysis considering the codes in secondary position because all our study sample was discharged with a diagnosis code in primary position (we did not extracted patients with the codes in secondary positions).

We explained in the limitations the reasons why we chose to focus on the codes in primary position, adding the following sentence: "We chose to limit our analysis only to the codes in primary position because, according to the Italian legislation, the primary diagnosis constitutes the main cause of the need for treatment and/or diagnostic tests, and is mainly responsible for the use of resources".

4\) Please define abbreviations upon first appearance in the text. PPV and NPV abbreviation was firstly used in the \"statistical analysis" section but the explanation is reported more than once in the "results" section.

Authors response: Thank you for your suggestion. We amended the text accordingly.

###### 

Submitted filename: Response to Reviewers.docx

###### 

Click here for additional data file.

10.1371/journal.pone.0235714.r003

Decision Letter 1

Virgili

Gianni

Academic Editor

© 2020 Gianni Virgili

2020

Gianni Virgili

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

22 Jun 2020

Accuracy of ICD-9 codes in identifying patients with peptic ulcer and gastrointestinal hemorrhage in the regional healthcare administrative database of Umbria.

PONE-D-20-09372R1

Dear Dr. Abraha,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Gianni Virgili

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

10.1371/journal.pone.0235714.r004

Acceptance letter

Virgili

Gianni

Academic Editor

© 2020 Gianni Virgili

2020

Gianni Virgili

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

24 Jun 2020

PONE-D-20-09372R1

Accuracy of ICD-9 codes in identifying patients with peptic ulcer and gastrointestinal hemorrhage in the regional healthcare administrative database of Umbria.

Dear Dr. Abraha:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Gianni Virgili

Academic Editor

PLOS ONE

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.
